Novo Nordisk

• Wegovy approved in Canada to combat risk of non fatal-heart attack

  Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

  Health

  Nov 27
  
• Wegovy set to launch in Canada. What to know about the weight-loss drug

  Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.

  Health

  May 2
  
• Advertisement
• Wegovy will be available for Canadians in spring 2024, company says

  Canadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company said Monday.

  Health

  Feb 5
• Advertisement
• Ozempic maker faces proposed class action lawsuit alleging ‘dangerous side effects’

  Novo Nordisk is facing a proposed nationwide class action lawsuit that alleges inadequate warning about severe side effects, including stomach paralysis linked to the drug.

  Canada

  Oct 31, 2023
• Ozempic refills being limited in B.C. amid supply issues

  B.C. Health Minister Adrian Dix said the measures are to protect the province’s supply.

  Health

  Aug 27, 2023
• How a Canadian scientist and a venomous lizard helped pave the way for Ozempic

  In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.

  Health

  Jun 28, 2023
• Ozempic: The trendy drug Americans are shopping for in Canada amid shortages

  Ozempic's popularity has caused shortages of the drug in the U.S. and Australia, and now consumers are turning their eyes to Canada as a cheap place to get the medication.

  Lifestyle

  Jan 19, 2023